Fundies.
English

Aclaris Therapeutics, Inc.

EDGAR
ACRS Current report (8-K) · filed 2026-10-27

Annual consolidated revenue for 2025: about Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 7.826M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 18.72M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

1.63 million Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg

2026 Q2 · Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg

Exact inputs and evidence
  • Revenue: 1629000 Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg Source

Operating margin

-1,487.91%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -24238000 Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg Source
  • Revenue: 1629000 Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg Source
Cash and cash equivalents
19.2 million Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg Source
Exact value

19167000 Unit_Standard_USD_pKmgm8m7mUaoQtQrBnNrdg

Long-term debt including current maturities
10.7 million Unit_Standard_USD_gE0GoJVfD0ynXgCI9e00_Q Source
Exact value

10731000 Unit_Standard_USD_gE0GoJVfD0ynXgCI9e00_Q

Shares outstanding
140 million Unit_Standard_shares_3krGVeGMSEq3EA9fDzgMcg Source
Exact value

139824273 Unit_Standard_shares_3krGVeGMSEq3EA9fDzgMcg

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2020-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -58.2%

    Prior period

    Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 18.72 million

    –

    Current period

    Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 7.83 million

    –

    Exact inputs and evidence

    7826000 − 18720000 = -10894000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

    18720000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    7826000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 67.14 million

    Prior period

    −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 132.07 million

    –

    Current period

    −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 64.92 million

    –

    Exact inputs and evidence

    -64923000 − -132065000 = 67142000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

    -132065000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -64923000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 27.04 million

    Prior period

    −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 20.08 million

    –

    Current period

    −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 47.11 million

    –

    Exact inputs and evidence

    -47113000 − -20075000 = -27038000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

    -20075000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -47113000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -8.3%

    Prior period

    Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 121,000

    –

    Current period

    Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 111,000

    –

    Exact inputs and evidence

    111000 − 121000 = -10000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

    121000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    111000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 7.83 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 84.2 million 1,076% of revenue
  • Operating income −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 76.38 million −976% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 11.45 million −146% of revenue
  • Net income −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 64.92 million −830% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 47.11 million −602% of revenue
  • Capital expenditure Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 111,000 1.4% of revenue
  • Free cash flow Derived −Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 47.22 million −603% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 858% of revenue.
  • 2025 Operating loss: operating costs were 1,076% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-3118720000 160652000 Derived -141932000 -9867000 Derived -132065000 -20196000 Derived
Source
2025 2025-01-01 – 2025-12-317826000 84201000 Derived -76375000 -11452000 Derived -64923000 -47224000 Derived
Source

Amounts are exact, in Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 7.8M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.20.2M15.2M10.1M5.1M0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ)Source evidence
2024Revenue18720000
2025Revenue7826000

Revenue growth

Change in revenue from the same financial period one year earlier.

-58.2% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5%-12%-29%-46%-63%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year-58.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -975.9% 2025
Net margin -829.6% 2025
Free cash flow margin -603.4% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.78%-205%-488%-771%-1,054%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-758.2%
2025Operating margin-975.9%
2024Net margin-705.5%
2025Net margin-829.6%
2024Free cash flow margin-107.9%
2025Free cash flow margin-603.4%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ -47.1M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.8M-9.9M-23.6M-37.2M-50.9M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ)Source evidence
2024Operating cash flow-20075000
2025Operating cash flow-47113000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ -47.2M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.8M-9.9M-23.6M-37.3M-51.0M20242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ)Source evidence
2024Free cash flow-20196000
2025Free cash flow-47224000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 132.07 million
Exact value

Exact value: -132065000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2024-01-01 – 2024-12-31: -132065000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 20.08 million
Exact value

Exact value: -20075000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2024-01-01 – 2024-12-31: -20075000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 121,000
Exact value

Exact value: 121000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2024-01-01 – 2024-12-31: 121000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 20.2 million
Calculation and evidence

-20075000 − 121000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

Exact free cash flow: -20196000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 64.92 million
Exact value

Exact value: -64923000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2025-01-01 – 2025-12-31: -64923000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 47.11 million
Exact value

Exact value: -47113000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2025-01-01 – 2025-12-31: -47113000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 111,000
Exact value

Exact value: 111000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

2025-01-01 – 2025-12-31: 111000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ 47.22 million
Calculation and evidence

-47113000 − 111000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

Exact free cash flow: -47224000 Unit_Standard_USD_4Vw5AOXxZESmAWR2JoVtrQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

146 filings · 6,295 latest values · 6,295 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001557746, 1557746, ACRS, edgar:1557746

Also known as Aclaris Therapeutics, Inc.